Academic Journal
A RIVA-DM Subanalysis Investigating Patients With Nonvalvular Atrial Fibrillation and Type 2 Diabetes Aged Under Versus Over 80 Years
| العنوان: | A RIVA-DM Subanalysis Investigating Patients With Nonvalvular Atrial Fibrillation and Type 2 Diabetes Aged Under Versus Over 80 Years |
|---|---|
| المؤلفون: | Craig I. Coleman Pharma D, FASHP, FACC, Olivia S. Costa PharmD, Christopher W. Brescia BS, Burcu Vardar MD, Khaled Abdelgawwad MSc, Lucas Hofmeister PhD, Nitesh Sood MD |
| المصدر: | Clinical and Applied Thrombosis/Hemostasis, Vol 28 (2022) |
| بيانات النشر: | SAGE Publishing, 2022. |
| سنة النشر: | 2022 |
| المجموعة: | LCC:Diseases of the circulatory (Cardiovascular) system |
| مصطلحات موضوعية: | Diseases of the circulatory (Cardiovascular) system, RC666-701 |
| الوصف: | Background Advanced age and type 2 diabetes (T2D) are common in patients with nonvalvular atrial fibrillation (NVAF). We evaluated the impact of age on the effectiveness and safety of rivaroxaban versus warfarin in this population. Methods We analyzed electronic health record data from November 2010, to December 2019 including adults with NVAF and T2D, newly started on rivaroxaban or warfarin. Propensity score-overlap weighted hazard ratios (HRs) for stroke/systemic embolism (SSE), hospitalization for major or clinically relevant nonmajor bleeding (CRNMB), vascular death, major adverse limb events (MALE), major bleeding, and intracranial hemorrhage (ICH) were calculated for older (≥80 years) and younger ( |
| نوع الوثيقة: | article |
| وصف الملف: | electronic resource |
| اللغة: | English |
| تدمد: | 1938-2723 10760296 |
| Relation: | https://doaj.org/toc/1938-2723 |
| DOI: | 10.1177/10760296221133083 |
| URL الوصول: | https://doaj.org/article/30a9a9056db54131b436e77329ceb625 |
| رقم الانضمام: | edsdoj.30a9a9056db54131b436e77329ceb625 |
| قاعدة البيانات: | Directory of Open Access Journals |
Full Text Finder | ResultId |
1 |
|---|---|
| Header |
edsdoj Directory of Open Access Journals edsdoj.30a9a9056db54131b436e77329ceb625 953 3 Academic Journal academicJournal 953.480224609375 |
| PLink |
https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.30a9a9056db54131b436e77329ceb625&custid=s6537998&authtype=sso |
| FullText |
Array
(
[Availability] => 0
)
Array ( [0] => Array ( [Url] => https://doaj.org/article/30a9a9056db54131b436e77329ceb625 [Name] => EDS - DOAJ [Category] => fullText [Text] => View record in DOAJ [MouseOverText] => View record in DOAJ ) [1] => Array ( [Url] => https://resolver.ebscohost.com/openurl?custid=s6537998&groupid=main&authtype=ip,guest&sid=EBSCO:edsdoj&genre=article&issn=19382723&ISBN=&volume=28&issue=&date=20221101&spage=&pages=&title=Clinical and Applied Thrombosis/Hemostasis&atitle=A%20RIVA-DM%20Subanalysis%20Investigating%20Patients%20With%20Nonvalvular%20Atrial%20Fibrillation%20and%20Type%202%20Diabetes%20Aged%20Under%20Versus%20Over%2080%20Years&id=DOI:10.1177/10760296221133083 [Name] => Full Text Finder (s6537998api) [Category] => fullText [Text] => Full Text Finder [Icon] => https://imageserver.ebscohost.com/branding/images/FTF.gif [MouseOverText] => Full Text Finder ) ) |
| Items |
Array
(
[Name] => Title
[Label] => Title
[Group] => Ti
[Data] => A RIVA-DM Subanalysis Investigating Patients With Nonvalvular Atrial Fibrillation and Type 2 Diabetes Aged Under Versus Over 80 Years
)
Array ( [Name] => Author [Label] => Authors [Group] => Au [Data] => <searchLink fieldCode="AR" term="%22Craig+I%2E+Coleman+Pharma+D%2C+FASHP%2C+FACC%22">Craig I. Coleman Pharma D, FASHP, FACC</searchLink><br /><searchLink fieldCode="AR" term="%22Olivia+S%2E+Costa+PharmD%22">Olivia S. Costa PharmD</searchLink><br /><searchLink fieldCode="AR" term="%22Christopher+W%2E+Brescia+BS%22">Christopher W. Brescia BS</searchLink><br /><searchLink fieldCode="AR" term="%22Burcu+Vardar+MD%22">Burcu Vardar MD</searchLink><br /><searchLink fieldCode="AR" term="%22Khaled+Abdelgawwad+MSc%22">Khaled Abdelgawwad MSc</searchLink><br /><searchLink fieldCode="AR" term="%22Lucas+Hofmeister+PhD%22">Lucas Hofmeister PhD</searchLink><br /><searchLink fieldCode="AR" term="%22Nitesh+Sood+MD%22">Nitesh Sood MD</searchLink> ) Array ( [Name] => TitleSource [Label] => Source [Group] => Src [Data] => Clinical and Applied Thrombosis/Hemostasis, Vol 28 (2022) ) Array ( [Name] => Publisher [Label] => Publisher Information [Group] => PubInfo [Data] => SAGE Publishing, 2022. ) Array ( [Name] => DatePubCY [Label] => Publication Year [Group] => Date [Data] => 2022 ) Array ( [Name] => Subset [Label] => Collection [Group] => HoldingsInfo [Data] => LCC:Diseases of the circulatory (Cardiovascular) system ) Array ( [Name] => Subject [Label] => Subject Terms [Group] => Su [Data] => <searchLink fieldCode="DE" term="%22Diseases+of+the+circulatory+%28Cardiovascular%29+system%22">Diseases of the circulatory (Cardiovascular) system</searchLink><br /><searchLink fieldCode="DE" term="%22RC666-701%22">RC666-701</searchLink> ) Array ( [Name] => Abstract [Label] => Description [Group] => Ab [Data] => Background Advanced age and type 2 diabetes (T2D) are common in patients with nonvalvular atrial fibrillation (NVAF). We evaluated the impact of age on the effectiveness and safety of rivaroxaban versus warfarin in this population. Methods We analyzed electronic health record data from November 2010, to December 2019 including adults with NVAF and T2D, newly started on rivaroxaban or warfarin. Propensity score-overlap weighted hazard ratios (HRs) for stroke/systemic embolism (SSE), hospitalization for major or clinically relevant nonmajor bleeding (CRNMB), vascular death, major adverse limb events (MALE), major bleeding, and intracranial hemorrhage (ICH) were calculated for older (≥80 years) and younger ( ) Array ( [Name] => TypeDocument [Label] => Document Type [Group] => TypDoc [Data] => article ) Array ( [Name] => Format [Label] => File Description [Group] => SrcInfo [Data] => electronic resource ) Array ( [Name] => Language [Label] => Language [Group] => Lang [Data] => English ) Array ( [Name] => ISSN [Label] => ISSN [Group] => ISSN [Data] => 1938-2723<br />10760296 ) Array ( [Name] => NoteTitleSource [Label] => Relation [Group] => SrcInfo [Data] => https://doaj.org/toc/1938-2723 ) Array ( [Name] => DOI [Label] => DOI [Group] => ID [Data] => 10.1177/10760296221133083 ) Array ( [Name] => URL [Label] => Access URL [Group] => URL [Data] => <link linkTarget="URL" linkTerm="https://doaj.org/article/30a9a9056db54131b436e77329ceb625" linkWindow="_blank">https://doaj.org/article/30a9a9056db54131b436e77329ceb625</link> ) Array ( [Name] => AN [Label] => Accession Number [Group] => ID [Data] => edsdoj.30a9a9056db54131b436e77329ceb625 ) |
| RecordInfo |
Array
(
[BibEntity] => Array
(
[Identifiers] => Array
(
[0] => Array
(
[Type] => doi
[Value] => 10.1177/10760296221133083
)
)
[Languages] => Array
(
[0] => Array
(
[Text] => English
)
)
[Subjects] => Array
(
[0] => Array
(
[SubjectFull] => Diseases of the circulatory (Cardiovascular) system
[Type] => general
)
[1] => Array
(
[SubjectFull] => RC666-701
[Type] => general
)
)
[Titles] => Array
(
[0] => Array
(
[TitleFull] => A RIVA-DM Subanalysis Investigating Patients With Nonvalvular Atrial Fibrillation and Type 2 Diabetes Aged Under Versus Over 80 Years
[Type] => main
)
)
)
[BibRelationships] => Array
(
[HasContributorRelationships] => Array
(
[0] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Craig I. Coleman Pharma D, FASHP, FACC
)
)
)
[1] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Olivia S. Costa PharmD
)
)
)
[2] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Christopher W. Brescia BS
)
)
)
[3] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Burcu Vardar MD
)
)
)
[4] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Khaled Abdelgawwad MSc
)
)
)
[5] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Lucas Hofmeister PhD
)
)
)
[6] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Nitesh Sood MD
)
)
)
)
[IsPartOfRelationships] => Array
(
[0] => Array
(
[BibEntity] => Array
(
[Dates] => Array
(
[0] => Array
(
[D] => 01
[M] => 11
[Type] => published
[Y] => 2022
)
)
[Identifiers] => Array
(
[0] => Array
(
[Type] => issn-print
[Value] => 19382723
)
[1] => Array
(
[Type] => issn-print
[Value] => 10760296
)
)
[Numbering] => Array
(
[0] => Array
(
[Type] => volume
[Value] => 28
)
)
[Titles] => Array
(
[0] => Array
(
[TitleFull] => Clinical and Applied Thrombosis/Hemostasis
[Type] => main
)
)
)
)
)
)
)
|
| IllustrationInfo |